Concepedia

Mark J. Cantwell

MJ

Statistics

Publications

11

Citations

1.4K

H-Index

11

Active since

1997

Affiliations

University of California San Diego(Current)

NewGen Therapeutics (United States)

The University of Texas MD Anderson Cancer Center

Duke University

Moffitt Cancer Center

Mark J. Cantwell is an author at University of California San Diego specializing in immunology, immunotherapy, and cancer immunology.

Publications per year

1997–2024

11

Publications

11

CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia

William G. Wierda, Mark J. Cantwell, Sandra J. Woods et al. · Blood · 2000 · 338 citations

Medicine, Immunology, Oncology +13

Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a

Tetsuya Fukuda, Liguang Chen, Tomoyuki Endo et al. · Proceedings of the National Academy of Sciences · 2008 · 313 citations · Full text

Life Sciences, Hematology, Immunology +14

Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells.

Kinshi Kato, Mark J. Cantwell, Shweta Sharma et al. · Journal of Clinical Investigation · 1998 · 238 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Acquired CD40-ligand deficiency in chronic lymphocytic leukemia

Mark J. Cantwell, Tinh Hua, Jim Pappas et al. · Nature Medicine · 1997 · 204 citations

Medicine, Hematology, Immunology +9

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain

Manisha Singh, Christina Vianden, Mark J. Cantwell et al. · Nature Communications · 2017 · 103 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 11